SCHEMBL3190069

SCHEMBL3190069

CC1C(=O)N(Cc2ccccc2)CC1NC(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ SCN9A Q15858 3/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ KDM1A O60341 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ MTNR1A P48039 1/20 0.40
▸ MTNR1B P49286 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ AKT1 P31749 1/20 0.39
▸ CTSS P25774 1/20 0.39
▸ CTSK P43235 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3190060 1.00 KMT2A (0.52) KMT2AL3MBTL1SCN9AMEN1ALDH1A1
SCHEMBL14502147 0.82 KMT2A (0.53) KMT2AL3MBTL1SCN9AMEN1ALDH1A1
SCHEMBL13434396 0.81 KMT2A (0.49) KMT2AL3MBTL1SCN9AALDH1A1TSHR
SCHEMBL13461299 0.81 KMT2A (0.49) KMT2AL3MBTL1SCN9AALDH1A1TSHR
SCHEMBL19121559 0.80 KMT2A (0.55) KMT2AL3MBTL1MEN1KDM1AMAOB
SCHEMBL3187533 0.80 KMT2A (0.55) KMT2AL3MBTL1MEN1KDM1AMAOB
SCHEMBL3187519 0.80 KMT2A (0.55) KMT2AL3MBTL1MEN1KDM1AMAOB
SCHEMBL7834998 0.80 KMT2A (0.55) KMT2AL3MBTL1MEN1KDM1AMAOB
SCHEMBL7835003 0.80 KMT2A (0.55) KMT2AL3MBTL1MEN1KDM1AMAOB
SCHEMBL1781856 0.80 KMT2A (0.55) KMT2AL3MBTL1MEN1KDM1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE41149-E1 Stereoisomerically pure 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-6-fluoro-1-[(1R,2S)-2-fluoro-1-cyclopropyl]-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid or a pharmaceutically acceptable salt thereof; antibacterial agents DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-02-23 — — US disclosed
US-RE41149-E1 Stereoisomerically pure 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-6-fluoro-1-[(1R,2S)-2-fluoro-1-cyclopropyl]-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid or a pharmaceutically acceptable salt thereof; antibacterial agents DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-02-23 — — US disclosed
CN-1010312-B PYRIDONECARBOXYLIC ACID DERIVATIVES AND PROCESS FOR PREPARING SAME KYORIN SEIYAKU KK (JP) 1990-11-07 — — CN disclosed
EP-0208210-B1 PYRIDONECARBOXYLIC ACID DERIVATIVES AND PROCESS FOR THEIR PREPARATION KYORIN PHARMACEUTICAL CO., LTD. (JP) 1990-10-24 — — EP disclosed
US-4753953-A Pyridonecarboxylic acid derivatives and antibacterial pharmaceutical compositions thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 1988-06-28 — — US disclosed
EP-0208210-A1 Pyridonecarboxylic acid derivatives and process for their preparation KYORIN PHARMACEUTICAL CO., LTD. (JP) 1987-01-14 — — EP disclosed
Send feedback